pemetrexed,cisplatin,gemcitabine,pembrolizumab,Nivolumab,Ipilimumab,Vinorelbine,Docetaxel,Carboplatin,Paclitaxel,Atezolizumab
merck,bms,Roche
['kn671', 'pembro']
key question in #kn671 is how many people on control arm who progressed got pembro+chemo (vs. chemo alone which is not soc)? here is some data from prior trials in our oa paper 57% of treated controls got cpi. that is poor
#asco23 os is meaningless 
Professor @ucsf, Physician-Scientist, Writer; More at @vkprasadlab @plenary_session, YouTube, #vpzd podcast & @Sensible__Med; Views are mine